Copy For Citation
Midi A., EKİCİ H., KUMANDAŞ A., Durmus O., Bodic B., Tiryaki M., ...More
MARMARA MEDICAL JOURNAL, vol.32, no.1, pp.27-32, 2019 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
32
Issue:
1
-
Publication Date:
2019
-
Doi Number:
10.5472/marumj.518821
-
Journal Name:
MARMARA MEDICAL JOURNAL
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.27-32
-
Keywords:
Algan hemostatic agent, Hemostasis, Rat, Bleeding control, Splenectomy, MEDICINAL-PLANT EXTRACT, ANKAFERD BLOOD STOPPER, N-ACETYL GLUCOSAMINE, FIBRIN SEALANT, POSTOPERATIVE ADHESIONS, ACHIEVING HEMOSTASIS, SPLENIC INJURY, SWINE MODEL, EFFICACY, MANAGEMENT
-
Recep Tayyip Erdoğan University Affiliated:
Yes
Abstract
Objective: Algan hemostatic agent (AHA) is a plant-based hemostatic agent produced in Turkey. Although, there is a great improvement in the hemostatic technologies, more effective hemostatic products are required to be produced. The aim of this study was to demonstrate the efficacy of AHA in a partial splenectomy model in rats. In addition, in this model, postoperative abdominal adhesion was evaluated.